Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis

…, ME Husni, TJ Love, E Lubrano… - Arthritis & …, 2016 - Wiley Online Library
Objective To update the 2009 Group for Research and Assessment of Psoriasis and Psoriatic
Arthritis (GRAPPA) treatment recommendations for the spectrum of manifestations affecting …

[HTML][HTML] Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021

…, J Latella, YY Leung, C Lindsay, E Lubrano… - Nature Reviews …, 2022 - nature.com
Since the second version of the Group for Research and Assessment of Psoriasis and
Psoriatic Arthritis (GRAPPA) treatment recommendations were published in 2015, therapeutic …

Consensus on a core set of domains for psoriatic arthritis.

…, D Van Der Heijde, E Husni, E Lubrano… - The Journal of …, 2007 - jrheum.org
A psoriatic arthritis (PsA) module was convened at OMERACT 8 in order to achieve
consensus on the core domains that should be included in randomized controlled trials and …

The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)

…, P Healy, EM Kerzberg, YJ Lee, E Lubrano… - Annals of the …, 2013 - ard.bmj.com
Objective To develop new composite disease activity indices for psoriatic arthritis (PsA).
Methods Data from routine clinic visits at multiple centres were collected in a systematic manner. …

International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid …

…, RD Grembiale, V Liakouli, R Lories, E Lubrano… - Autoimmunity …, 2017 - Elsevier
Autoimmune diseases are a complex set of diseases characterized by immune system
activation and, although many progresses have been done in the last 15 years, several unmet …

Drug-induced lupus erythematosus.

P Sarzi-Puttini, F Atzeni, F Capsoni, E Lubrano… - …, 2005 - search.ebscohost.com
Drug-induced lupus is a syndrome which share symptoms and laboratory characteristics
with idiopathic systemic lupus erythematosus (SLE). The terms drug-induced lupus (DIL) and …

Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study

…, C Salvarani, JR Kalden, E Lubrano… - The Journal of …, 2011 - jrheum.org
Objective. During OMERACT 8, delegates selected patient global assessment (PGA) of
disease as a domain to be evaluated in randomized controlled trials in psoriatic arthritis (PsA). …

Outcome measures in psoriatic arthritis.

…, PS Helliwell, O Fitzgerald, A Cauli, E Lubrano… - The Journal of …, 2007 - jrheum.org
Psoriatic arthritis (PsA), an inflammatory arthritis associated with psoriasis usually
seronegative for rheumatoid factor, has emerged as a more common and severe disease than …

Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgia

A Marchesoni, F Atzeni, A Spadaro, E Lubrano… - The Journal of …, 2012 - jrheum.org
Objective. To identify the clinical features that can help to distinguish between psoriatic
arthritis (PsA) and fibromyalgia (FM). Methods. Our cross-sectional study was carried out in 10 …

Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries

…, SZ Aydin, L Eder, I Gaydukova, E Lubrano… - Annals of the …, 2019 - ard.bmj.com
Background The objective was to compare different definitions of remission and low disease
activity (LDA) in patients with psoriatic arthritis (PsA), based on both patients’ and physicians…